REGN34:BVMF
Regeneron Pharmaceuticals Inc BDR
R$62,76
arrow_upward
+0,79%(+0,49) 1 HR
13 Okt, 11.12.19 GMT-3 · BRL
search
Semua simbol
| Simbol | Harga | Perubahan | Persentase Perubahan |
|---|
insights_autoMembuat insight teratas untuk REGN34...
Pembukaan
R$62,76
Tinggi
R$62,76
Rendah
R$62,76
Kapitalisasi pasar
77,43 M
Volume rata-rata
910,00
Volume
10,00
Harga tinggi dalam 52 minggu terakhir
R$73,13
Harga rendah dalam 52 minggu terakhir
R$49,91
Saham beredar
101,14 jt
Jumlah karyawan
15 rb
Pembukaan
R$62,76
Tinggi
R$62,76
Rendah
R$62,76
Kapitalisasi pasar
77,43 M
Volume rata-rata
910,00
Volume
10,00
Harga tinggi dalam 52 minggu terakhir
R$73,13
Harga rendah dalam 52 minggu terakhir
R$49,91
Saham beredar
101,14 jt
Jumlah karyawan
15 rb
Artikel berita
Dari sumber web dan partner berita
ad-hoc-news.de
·
3 jam yang lalu
RBC raises target for Regeneron stock to USD 810.00
The Globe and Mail
·
7 jam yang lalu
Citi Keeps Their Hold Rating on Regeneron (REGN)
ad-hoc-news.de
·
7 jam yang lalu
Regeneron reports Pasatru data and Citi holds Regeneron stock
ad-hoc-news.de
·
8 jam yang lalu
Sanofi expanded Regeneron alliance: Sanofi stock gains 1.34 percent
Profil
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
Tentang Regeneron Pharmaceuticals Inc BDR
CEOLeonard Schleifer
Karyawan15,3 rb
Didirikan1988
Kantor PusatTarrytown, New York, Amerika Serikat
Sektor-
Situsregeneron.com